Lyra Therapeutics (LYRA) Q3 2024 Earnings

14AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-0.74
-0.58
-0.42
-0.26

Details

Expected EPS
-0.3343
Actual EPS
-0.74
Surprise EPS
-0.41
Surprise Percent
+121.36%

Description

Lyra Therapeutics (LYRA) has reported earnings of -0.74 per share for Q3 2024.

0 Comments

Share your thoughts